Kamyar Kalantar-Zadeh M.D. to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
1.632
-
Longer Predialysis ACEi/ARB Utilization Is Associated With Reduced Postdialysis Mortality. Am J Med. 2020 09; 133(9):1065-1073.e3.
Score: 0.672
-
Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease. J Am Coll Cardiol. 2014 Feb 25; 63(7):650-658.
Score: 0.431
-
The crossroad of RAAS modulation, inflammation, and oxidative stress in dialysis patients: light at the end of the tunnel? J Am Soc Nephrol. 2012 Feb; 23(2):189-91.
Score: 0.379
-
Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney Int. 2016 08; 90(2):262-271.
Score: 0.128
-
Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system. Am J Hypertens. 2012 Mar; 25(3):379-88.
Score: 0.024